Browse studies

Find your next paid study

27,295 recruiting studies available now

Optimizing High Flow Nasal Cannula Oxygenation in Pediatric Airway Procedures: a Randomized Study

The purpose of this study is to investigate which flow rate (higher versus lower) is most effective at increasing apneic time and preventing greater than 5% dr…

Airway Disorder

Estimated

~$10 – $750

Actual pay is set by the research site.

The University of Texas Health Science Center, HoustonNCT06947902

Phase 4

Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction

This research study evaluates a prescription eye drop called Vevye® (cyclosporine 0.1%) for adults who have meibomian gland dysfunction (MGD), a common eye con…

Meibomian Gland Dysfunction (MGD)

Estimated

~$25 – $1,000

Actual pay is set by the research site.

University of Alabama at BirminghamNCT07224529

Observational

Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF IV

Six million Americans live with atrial fibrillation (AF), a heart rhythm abnormality that is a major risk factor for stroke and only half of those AF patients …

Atrial Fibrillation

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Massachusetts, WorcesterNCT05236556

Quantification of Visually Evoked Cortical Potentials in Individuals With Hearing Loss

This research is being done to determine whether a test that measures a "Visual Evoked Potential" can be used in a new way for individuals that have hearing lo…

Sensorineural Hearing LossHearing Loss

Estimated

~$10 – $750

Actual pay is set by the research site.

Dartmouth-Hitchcock Medical CenterNCT05107466

Observational

Behavioral Treatment of Insomnia in Active-Duty Service Members With Traumatic Brain Injury

The objective of the study is to conduct a randomized controlled trial of Cognitive Behavioral Therapy for Insomnia (CBT-I) in a sample of active-duty sailors …

InsomniaTBI (Traumatic Brain Injury)

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Noctem, LLCNCT06867666

Phase 2

A Phase 2 Trial of Emapalumab for the Prevention of CAR-T Cell Associated Toxicities

This research study involves assessing the impact of emapalumab as preventative management of CAR-T related cytokine release syndrome in participants with Non-…

Large B-cell LymphomaRelapsed Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma+4 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Marcela V. Maus, M.D.,Ph.D.NCT06550141

Phase 1

A Phase 1, Open-Label, Multicenter Study of INCA036978 in Participants With Myeloproliferative Neoplasms

This study will be conducted to determine the safety, tolerability, dose-limiting toxicity (DLT)s, and maximum tolerated dose (MTD) and/or recommended dose for…

Myeloproliferative Neoplasms

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Incyte CorporationNCT07441694

Observational

Heightening Oncologist-Latino/a Cancer Patient Alliances (HOLA) Intervention Pilot Study

The patient-clinician relationship is fundamental to providing high-quality patient-centered medical care. A therapeutic alliance (TA) is a patient clinician r…

Therapeutic Alliances

Estimated

~$10 – $750

Actual pay is set by the research site.

Rutgers, The State University of New JerseyNCT07576530

Phase 3

Randomized, Open-Label Study of the Bria-IMT Regimen and Check Point Inhibitor vs Physicians' Choice in Advanced Metastatic Breast Cancer.

This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor \[Retifanlim…

Breast CancerMetastatic Breast CancerBreast Neoplasm+2 more

Estimated

~$50 – $2,100

Actual pay is set by the research site.

BriaCell Therapeutics CorporationNCT06072612

Phase 2

A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Patients With Endocrine- Resistant Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer With Chromosome 8P Loss and Without a PIK3CA Mutation

A study to evaluate the efficacy and safety of triplet combination of inavolisib plus ribociclib and fulvestrant versus placebo plus ribociclib and fulvestrant…

Breast Cancer

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Hoffmann-La RocheNCT07405801

Phase 1

A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of Aritinercept, a Dual BAFF/APRIL Inhibitor, in Patients With Generalized Myasthenia Gravis

This clinical study will enroll patients with generalized myasthenia gravis (gMG). The goal of this clinical study is to assess the safety, tolerability, effec…

Myasthenia Gravis, Generalized

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Aurinia Pharmaceuticals Inc.NCT07596901

Phase 1

MK-2400-01A Substudy: A Phase 1/2, Open-label Umbrella Substudy of MK-2400-U01 Master Protocol to Evaluate the Safety and Efficacy of Ifinatamab Deruxtecan-based Treatment Combinations or Ifinatamab Deruxtecan Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (IDeate-Prostate02)

The purpose of this substudy is to assess the efficacy and safety of ifinatamab deruxtecan (I-DXd), given alone or with other treatments in participants with m…

Castration-Resistant Prostatic CancerMetastasis

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT06863272